80200-09-5 Usage
General Description
1-(4-hydroxybenzyl)pyrazole is a chemical compound with the molecular formula C12H11N3O. It is a pyrazole derivative with a hydroxybenzyl group attached. 1-(4-hydroxybenzyl)pyrazole has been reported to have potential therapeutic effects, including antitumor and anti-inflammatory activities. It has also been studied for its possible role in regulating the production of the stress hormone cortisol. Its structure and properties make it a promising candidate for further research and development as a potential pharmaceutical agent for various medical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 80200-09-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,0,2,0 and 0 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 80200-09:
(7*8)+(6*0)+(5*2)+(4*0)+(3*0)+(2*0)+(1*9)=75
75 % 10 = 5
So 80200-09-5 is a valid CAS Registry Number.
InChI:InChI=1/C10H10N2O/c13-10-4-2-9(3-5-10)8-12-7-1-6-11-12/h1-7,13H,8H2
80200-09-5Relevant articles and documents
Microwave-Assisted Generation and Capture by Azoles of ortho-Quinone Methide Intermediates under Aqueous Conditions
González-Pelayo, Silvia,López, Luis A.
, p. 6003 - 6007 (2017)
An efficient activator-free protocol for the coupling of o-hydroxybenzyl alcohols and azoles in water has been developed. This C–N bond-formation process is supposed to proceed through an ortho-quinone methide intermediate. A broad range of o-hydroxybenzy
Structure-activity studies on a 1,2,3-triazole derivative, a potent in vitro inhibitor of prostaglandin synthesis: The role of the heterocyclic ring
Biagi,Dell'Omodarme,Ferretti,Giorgi,Livi,Scartoni
, p. 335 - 344 (2007/10/02)
This paper reports further structural modifications concerning the 1,2,3- triazole ring of the compound A, an effective in vitro inhibitor of prostaglandin synthesis. The introduction of different heterocyclic rings provided further information about of t
